Epidemiology of axial spondyloarthritis: an update

R Wang, MM Ward - Current opinion in rheumatology, 2018 - journals.lww.com
Epidemiology of axial spondyloarthritis: an update : Current Opinion in Rheumatology
Epidemiology of axial spondyloarthritis: an update : Current Opinion in Rheumatology Log …

[PDF][PDF] One year in review 2017: spondyloarthritis

R Terenzi, S Monti, G Tesei, L Carli - Clin Exp Rheumatol, 2018 - clinexprheumatol.org
The term spondyloarthritis (SpA) represents a condition characterised by a broad spectrum
of clinical manifestations, laboratory abnormalities and imaging features; in particular, SpA is …

[HTML][HTML] Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades

SSR Crossfield, H Marzo-Ortega, SR Kingsbury… - RMD open, 2021 - rmdopen.bmj.com
Objectives To assess changes in ankylosing spondylitis (AS) incidence, prevalence and
time to diagnosis, between 1998 and 2017. Methods Using UK GP data from the Clinical …

Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic …

IC Scott, R Whittle, J Bailey, H Twohig… - The Lancet Regional …, 2022 - thelancet.com
Background Contemporary data on rheumatoid arthritis (RA), psoriatic arthritis (PsA) and
axial spondyloarthritis (SpA) epidemiology in England are lacking. This knowledge is crucial …

[HTML][HTML] Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external …

Y Ingrasciotta, A Spini, L L'Abbate, ES Fiore… - Pharmacological …, 2024 - Elsevier
To date, no population-based studies have specifically explored the external validity of
pivotal randomized clinical trials (RCTs) of biologics simultaneously for a broad spectrum of …

Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study

A Ogdie, DB Shin, TJ Love, JM Gelfand - Rheumatology, 2022 - academic.oup.com
Objective Increasing psoriasis severity has been associated with comorbidities including
cardiovascular disease. The objective of this study was to examine the association of …

Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: a set of parallel case-control studies

E Meer, T Thrastardottir, X Wang, M Dubreuil… - The Journal of …, 2022 - jrheum.org
Objective To compare potential risk factors for the diagnosis of psoriatic arthritis (PsA),
psoriasis (PsO), rheumatoid arthritis (RA), and ankylosing spondylitis (AS). Methods Four …

Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis

M Dubreuil, Q Louie-Gao, CE Peloquin… - Annals of the …, 2018 - ard.bmj.com
Objectives Spondyloarthritis (SpA) is associated with an increased risk of myocardial
infarction (MI) due to underlying inflammation and possibly due to medications such as …

[HTML][HTML] PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation

JN Swerdel, M Schuemie, G Murray, PB Ryan - Journal of Biomedical …, 2022 - Elsevier
Purpose Phenotype algorithms are central to performing analyses using observational data.
These algorithms translate the clinical idea of a health condition into an executable set of …

A glance into the future of diagnosis and treatment of spondyloarthritis

V Navarro-Compán, J Ermann… - Therapeutic Advances …, 2022 - journals.sagepub.com
The last two decades have seen major developments in the field of spondyloarthritis (SpA),
but there are still important unmet needs to address. In the future, we envisage important …